Search research articles
Contact Us
Filters
Showing results (451-460 of 531) with videos related to
Page
of 54
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 25, 2021
Validity of 2020 vancomycin consensus recommendations and further guidance for practical application
Michael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Journal of the Pediatric Infectious Diseases Society
|
July 14, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Jennifer Le, Thomas Lodise, et al.
Microbiology Spectrum
|
January 11, 2024
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 25, 2020
Questions on Vancomycin Dosing
Michael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Open Forum Infectious Diseases
|
May 16, 2020
Early Experience With Eravacycline for Complicated Infections
Sara Alosaimy, Kyle C Molina, Kimberly C Claeys, et al.
Infectious Diseases and Therapy
|
November 2, 2022
International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections
E J Zasowski, T D Trinh, K C Claeys, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2020
Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities
Taylor Morrisette, Katherine L Lev, Razieh Kebriaei, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 13, 2019
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study
Sarah C J Jorgensen, Evan J Zasowski, Trang D Trinh, et al.
Open Forum Infectious Diseases
|
January 16, 2020
Multicenter Cohort of Patients With Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Erin K McCreary, Ravina Kullar, Matthew Geriak, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006
Helio S Sader, Paul D Fey, Ajit P Limaye, et al.
Page
of 54
Search research articles
Search
Showing results (451-460 of 531) with videos related to
Sort By:
Page
of 54
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
March 25, 2021
Validity of 2020 vancomycin consensus recommendations and further guidance for practical application
Michael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Journal of the Pediatric Infectious Diseases Society
|
July 14, 2020
Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J Rybak, Jennifer Le, Thomas Lodise, et al.
Microbiology Spectrum
|
January 11, 2024
Cefiderocol: early clinical experience for multi-drug resistant gram-negative infections
Amer El Ghali, Ashlan J Kunz Coyne, Kristen Lucas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 25, 2020
Questions on Vancomycin Dosing
Michael J Rybak, Jennifer Le, Thomas P Lodise, et al.
Open Forum Infectious Diseases
|
May 16, 2020
Early Experience With Eravacycline for Complicated Infections
Sara Alosaimy, Kyle C Molina, Kimberly C Claeys, et al.
Infectious Diseases and Therapy
|
November 2, 2022
International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections
E J Zasowski, T D Trinh, K C Claeys, et al.
Antimicrobial Agents and Chemotherapy
|
June 24, 2020
Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities
Taylor Morrisette, Katherine L Lev, Razieh Kebriaei, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 13, 2019
Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study
Sarah C J Jorgensen, Evan J Zasowski, Trang D Trinh, et al.
Open Forum Infectious Diseases
|
January 16, 2020
Multicenter Cohort of Patients With Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Erin K McCreary, Ravina Kullar, Matthew Geriak, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2009
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006
Helio S Sader, Paul D Fey, Ajit P Limaye, et al.
Page
of 54